Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia

NCT06939634 is registered in ClinicalTrials.gov with Wandercraft as lead sponsor.

NCT NCT06939634
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06939634 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Usability and Safety of the System Atalante in Patients With High Paraplegia and Tetraplegia
Lead sponsor
Wandercraft
Phase
Observational
Overall status
Completed
Start date
June 1, 2024
Completion date
September 1, 2024
Enrollment
35 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

guillain barré syndrome, paraplegia, complete, paraplegia, incomplete, spinal cord injury, tetraplegia/tetraparesis